PCCW Limited
PCCW Limited (PCWLF) Financial Performance & Income Statement Overview
Review PCCW Limited (PCWLF) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
PCCW Limited (PCWLF) Income Statement & Financial Overview
Review PCCW Limited PCWLF income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $19.86B | $17.70B | $19.50B | $9.75B |
| Cost of Revenue | $13.98B | $12.62B | $13.89B | $4.91B |
| Gross Profit | $5.88B | $5.08B | $5.61B | $4.84B |
| Gross Profit Ratio | $0.30 | $0.29 | $0.29 | $0.50 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $2.49B | $3.08B | $2.47B | $3.27B |
| Operating Expenses | $2.49B | $3.08B | $2.47B | $3.38B |
| Total Costs & Expenses | -$16.47B | $15.70B | $16.36B | $8.29B |
| Interest Income | $65.00M | $68.00M | $78.00M | $648.50M |
| Interest Expense | $1.43B | $1.39B | $1.51B | $0.00 |
| Depreciation & Amortization | $3.79B | $2.42B | $4.07B | $1.32B |
| EBITDA | $7.50B | $4.42B | $7.21B | $2.89B |
| EBITDA Ratio | $0.38 | $0.25 | $0.37 | $0.30 |
| Operating Income | $3.39B | $2.00B | $3.14B | $1.57B |
| Operating Income Ratio | $0.17 | $0.11 | $0.16 | $0.16 |
| Other Income/Expenses (Net) | -$1.11B | -$1.14B | -$2.33B | -$758.50M |
| Income Before Tax | $2.28B | $860.00M | $1.77B | $812.50M |
| Income Before Tax Ratio | $0.11 | $0.05 | $0.09 | $0.08 |
| Income Tax Expense | $521.00M | $326.00M | $47.00M | $23.50M |
| Net Income | $162.00M | -$462.00M | $15.00M | $7.50M |
| Net Income Ratio | $0.008 | -$0.03 | $0.001 | $0.001 |
| EPS | $0.02 | -$0.06 | $0.002 | $0.001 |
| Diluted EPS | $0.02 | -$0.06 | $0.002 | $0.001 |
| Weighted Avg Shares Outstanding | $7.73B | $7.73B | $7.73B | $7.93B |
| Weighted Avg Shares Outstanding (Diluted) | $7.73B | $7.73B | $7.73B | $7.73B |
Financial performance has remained strong, with revenue growing from $9.75B in Q3 2023 to $19.86B in Q4 2024. Gross profit continued to perform well, with margins at 30% in the latest quarter. Operating income reached $3.39B in Q4 2024, holding a steady 17% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $7.50B. Net income rose to $162.00M, keeping EPS at $0.02. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan